Form 8-K - Current report:
SEC Accession No. 0001628280-24-013705
Filing Date
2024-03-29
Accepted
2024-03-29 09:05:28
Documents
15
Period of Report
2024-03-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcnnf-20240325.htm   iXBRL 8-K 33083
2 EX-16.1 trulieveformattachmentxc.htm EX-16.1 1274
6 trulieveformattachmentxc001.jpg GRAPHIC 67756
  Complete submission text file 0001628280-24-013705.txt   242365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcnnf-20240325.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcnnf-20240325_lab.xml EX-101.LAB 19410
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcnnf-20240325_pre.xml EX-101.PRE 11036
18 EXTRACTED XBRL INSTANCE DOCUMENT tcnnf-20240325_htm.xml XML 2433
Mailing Address 6749 BEN BOSTIC ROAD QUINCY FL 32351
Business Address 6749 BEN BOSTIC ROAD QUINCY FL 32351 8502988866
Trulieve Cannabis Corp. (Filer) CIK: 0001754195 (see all company filings)

EIN.: 581882476 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56248 | Film No.: 24802220
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)